Safaricom Limited (SCOM.ke) 2008 Presentation

first_imgSafaricom Limited (SCOM.ke) listed on the Nairobi Securities Exchange under the Technology sector has released it’s 2008 presentation For more information about Safaricom Limited (SCOM.ke) reports, abridged reports, interim earnings results and earnings presentations, visit the Safaricom Limited (SCOM.ke) company page on AfricanFinancials.Document: Safaricom Limited (SCOM.ke)  2008 presentation Company ProfileSafaricom Limited is an integrated telecommunications company in Kenya providing mobile, fixed voice, data, SMS, Internet and M-PESA services. The company sells mobile phones and tablets as well as broadband modems and routers. It also offers its customers data bundles for pre- and post-paid customers; pre- and post-paid voice plans and SMS services for national and international roaming; Okoa Jahazi for emergency top-up credit; and Flex plans for browsing, calling and SMSing. Bonga Points is a customer loyalty programme and M-PESA is a mobile telephone service to deposit, transfer and withdraw money as well as pay for goods and services. Other services offered include website and email, calling and cloud and hosting services. Safaricom Limited’s head office is in Nairobi, Kenya. Safaricom Limited is listed on the Nairobi Securities Exchangelast_img read more

Barclays share price down 52% in a month! Should I add it to my ISA?

first_img See all posts by Rachael FitzGerald-Finch “This Stock Could Be Like Buying Amazon in 1997” Image source: Getty Images Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Rachael FitzGerald-Finch has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Rachael FitzGerald-Finch | Friday, 17th April, 2020 | More on: BARC I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Barclays (LSE: BARC) share price has crashed 52% over the last month. Since the bank released its annual figures, its share price has dropped even faster than the FTSE 100 itself.Unfortunately for Barclays, this drop was straight after a decent set of financial figures for 2019. Turnover improved slightly, profits were up, and expenses were down. Moreover, shareholders were rewarded with a decent dividend.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…So, is the bank a good buying opportunity for your new Stocks and Shares ISA allowance? Barclays share price underwhelmsBarclays share price continues to be disappointing despite the solid results from 2019. Pre-tax profits improved 25% to £4.4bn. This seems fairly spectacular. However, much of this increase was due to cost-cutting and lower misconduct charges. Sadly, turnover has been pretty flat over the last five years, despite the small 2.3% increase for 2019.This must be viewed in context though. Banks profits are tied to interest rates. The really low interest rates of recent times make it harder for banks to improve profit margins without taking more risk. And the crash of 2008 and 2009 demonstrated the consequences of the latter. The government’s response to the coronavirus pandemic cuts interest rates further. Currently GBP LIBOR is 0.75%. This, when combined with distressed borrowers and an imminent recession, is putting more downward pressure on Barclays shares.But I think investors must be realistic with expectations. It’s highly likely profitability will contract this year. And this will affect any reintroduction of Barclays’ dividend, cancelled at the Bank of England’s request. A future scrip dividend?Prior to the pandemic, Barclay’s 3.21% dividend yield was well-covered and relatively safe. However, Barclay’s uses a scrip dividend, so investors can choose payment in shares instead of cash. An advantage to shareholders is more shares without stamp duty or commissions. And Barclays don’t need to generate the cash to pay it.However, the use of a scrip dividend also raises payout ratios and dividend per share figures. And it also adds capital to the balance sheet, effectively converting retained profits into share capital. A large scrip dividend can have a diluting effect on earnings per share because more shares are in circulation. This may adversely affect the share price. When comparing Barclays with other banks, this is something to bear in mind. I think it’s possible that Barclays will reinstate their scrip as soon as they are able to. Banks will need to encourage investors but the upcoming economic recovery will require their cash.According to the FPC, UK banks are well capitalised to withstand severe coronavirus disruption. It also stated it will take further action to underpin the banks if required. This bodes well for the future of the sector.Some US analysts have given Barclay’s share price a target of 150p for 2020. Barclays is currently trading around 86p against a tangible net asset value of 335p. I think the latter could increase as banks lend recovery money to businesses and individuals.With all this in mind, I think this FTSE 100 stock is attractive. I’ll be adding it to my Stocks and Shares ISA.center_img I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Our 6 ‘Best Buys Now’ Shares Simply click below to discover how you can take advantage of this. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Enter Your Email Address Barclays share price down 52% in a month! Should I add it to my ISA?last_img read more

I’d listen to Warren Buffett and buy crashing UK shares to get rich and retire early

first_img Enter Your Email Address I’d listen to Warren Buffett and buy crashing UK shares to get rich and retire early I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Our 6 ‘Best Buys Now’ Shares “This Stock Could Be Like Buying Amazon in 1997” I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Image source: The Motley Fool See all posts by Peter Stephens Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Simply click below to discover how you can take advantage of this. Peter Stephens | Saturday, 8th August, 2020 Buying crashing UK shares right now may seem to be a risky move. After all, the stock market faces a very uncertain future that includes threats such as a second wave of coronavirus, as well as other challenges such as Brexit and rising unemployment.However, some of the world’s most successful investors have often decided to buy shares at such times. For example, Warren Buffett prefers to purchase high-quality businesses when they face uncertain near-term outlooks.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…In doing so, you can access lower valuations that may produce higher returns in the long run. Over time, this may improve your prospects of retiring early.Bargain UK sharesEven though some UK shares have rebounded following the market crash, the FTSE 100 and FTSE 250 both trade significantly lower than they did at the start of the year. As such, it appears as though investors are pricing in some of the risks they face that could derail their financial prospects.Therefore, an opportunity currently exists for long-term investors to purchase high-quality companies at low prices. This plan has been used successfully in the past by Warren Buffett. He often waits for such periods before buying companies. In doing so, he is able to buy businesses that have solid balance sheets and wide economic moats at a discount to what he feels they are worth.This not only provides an opportunity to generate relatively high returns as UK shares recover, it also potentially means less risk due to the existence of a margin of safety. Therefore, now could be the right time to buy a selection of FTSE 100 and FTSE 250 stocks while investor sentiment is weak and their prices reflect the ongoing risks faced by the world economy.Short-term investingOf course, a second market crash could cause the prices of UK shares to fall in the short run. However, in the eyes of investors such as Warren Buffett, this is likely to present an even more attractive buying opportunity rather than a reason to worry. Since the stock market has always recovered from its various bear markets to post recoveries, buying at even lower share prices could mean higher returns in the long run.Moreover, most investors who are buying shares for their retirement portfolios are likely to have a long-term time horizon. Therefore, a temporary decline in portfolio values is unlikely to have a direct impact on their retirement income – as long as the shares they buy survive a period of economic difficulty. As such, by taking a long-term view and following the advice of successful investors such as Warren Buffett, you can use the recent market crash to your advantage and build an appealing portfolio of stocks that helps to bring your retirement date along sooner than expected. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!last_img read more

24-hour gaming marathon to raise funds for SKFF

first_img Melanie May | 13 September 2016 | News Tagged with: Fundraising ideas Gaming Scotland 24-hour gaming marathon to raise funds for SKFF A 24-hour gaming marathon is taking place in October, to raise funds for the Sick Kids Friends Foundation (SKFF).Sick Kids Save Point is organised by gamer Tom Freeman on behalf of the charity, and is now in its seventh year. So far it has raised £94,000 for the SKFF, and this year takes place the weekend of Saturday 15th and Sunday 16th October.Participants can take part on a console, computer, mobile phone, on social media or by playing board games, and can do so as part of a team or on their own. Entry is free, and participants are asked to tweet updates using the hashtag #sksp on Twitter during the marathon.All funds raised from the event will go towards supporting Edinburgh’s Royal Hospital for Sick Children’s move to a new, purpose-built home at Little France in 2017, for which the SKFF has committed to contribute £2.9million in enhancements, patient and family services, and therapies.Freeman said:“The whole thing started in 2009. My daughter was just a baby and I wasn’t getting much sleep anyway, so the idea of playing games for 24 hours seemed like a novel fundraising idea for a vital local charity. I had no idea it would snowball into an annual event which has seen hundreds of people take part from around the world.”  105 total views,  1 views today Advertisement  106 total views,  2 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis11 About Melanie May Melanie May is a journalist and copywriter specialising in writing both for and about the charity and marketing services sectors since 2001. She can be reached via www.thepurplepim.com. AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis11last_img read more

Guatemala erupciones naturales y políticas

first_imgONU, Nueva York, 18 de junio.El 12 de junio entraron a la capital de Guatemala miles de indígenas y campesinas/os, organizándose en cuatro columnas para entrar al Parque Central. Venían en respuesta al llamado a un paro nacional convocado por el Comité de Desarrollo Campesino (Codeca) para exigir justicia en las muertes de varios defensores de derechos humanos de esa organización. En el último mes han sido asesinados cinco miembros de Codeca y varios otros líderes campesinos que no formaban parte de la organización.Esta acción viene durante un periodo peligroso en Guatemala, ya que actualmente están activos los volcanes de Pacaya, Santiago, y Fuego. Ese último volcán ya ha tenido varias erupciones en las últimas semanas que han devastado las aldeas cercanas y han exacerbado una crisis política en el país.Días antes de que llegara Codeca a la capital, habían salido ciudadanos de ésta a demandar la salida del presidente Jimmy Morales por su corrupción y su fracaso en manejar la emergencia del volcán.Además de exigir justicia para los defensores asesinados, Codeca también pedía la salida del presidente y su gabinete. Pero también pedían la salida de los diputados corruptos del Congreso. En la manifestación en la plaza, varios líderes de Codeca y sus aliados proponían un proceso de Asamblea Nacional Constituyente Popular y Plurinacional.Se oponían al llamado “pacto de corruptos” que, aprovechándose de que el país tenía ocupada su atención en socorrer a las víctimas del volcán, intentaba pasar el partido gobernante Frente de Convergencia Nacional (FCN). Así llamaban a la iniciativa del gobierno que daría impunidad al FCN ante investigaciones de financiamiento electoral ilícito.A la hora de escribir, se han cancelado los diputados del FCN y el presidente está siendo investigado por el Tribunal Electoral Supremo. A lo largo del país las demostraciones han continuado los últimos días.Jimmy Morales, herramienta de la clase gobernanteEn 2015, el pueblo guatemalteco tomó las calles y forzó la salida del presidente Otto Pérez Molina, junto con la mayoría de sus ministros. Era una respuesta a la crisis de los servicios sociales causado por el robo descontrolado de los fondos de gobierno por parte de los políticos y sus amigos en la oligarquía. El presidente renunció y la Comisión Internacional Contra la Impunidad en Guatemala (CICIG) inició un proceso legal.Lo que faltó en 2015 fue una alternativa decisiva al poder de los militares y la oligarquía que habían gobernado el país por tanto tiempo. Con los dos partidos políticos mayoritarios desacreditados en la mente del pueblo por escándalos de corrupción, llegó al poder Jimmy Morales, popular actor cómico y candidato de un partido formado por ex-militares.¿Cual ha sido el enfoque de Morales en su presidencia? Es obvio que no es atender a las necesidades sociales, ya que incluso antes del volcán las carreteras estaban en pésimas condiciones, los hospitales no tenían medicinas y el país lideraba la América Latina en malnutrición infantil. Como denunciaba Codeca, el país está a punto de caer en un estado fallido.Como prueba de eso, Jimmy Morales ha propuesto referendos sobre la frontera con Belice, incentivado la inversión de capital estadounidense y europea en el país y además, movió la embajada guatemalteca en Israel a Jerusalén días después de que Trump anunciara esa decisión en EUA.Mientras las naciones mayas y las/os campesinos se movilizaban para ayudar a las/os damnificados del volcán, el gobierno decía que no había “ni un sólo centavo” en el presupuesto. Cuando llegaban camiones e individuos de los países vecinos de Honduras y El Salvador con ayuda, no les permitían cruzar la frontera. Pronto el ejército tomó control de las operaciones y ahora se reporta que las donaciones en los centros de acopio no han llegado a las víctimas.En los meses siguientes será necesario una gran campaña de reconstrucción para la recuperación luego del desastre. Aunque la oligarquía puede ignorar esa necesidad, es posible que se aproveche de la emergencia sometiendo contratos lujosos que beneficien a sus empresas y a sus inversionistas extranjeros. Como siempre, será el pueblo el que sufre.El ejemplo de Puerto Rico, y la actual destrucción de sus servicios públicos, debería ser una advertencia para el pueblo de Guatemala. Es cierto que, a diferencia del archipiélago, Guatemala no es una colonia formal de los Estados Unidos. Pero sí como neocolonia, está dominada por el imperialismo estadounidense y europeo que extrae grandes ganancias del país con la ayuda de la oligarquía que se queda con lo que sobra.El movimiento popular como alternativa a la oligarquíaEl futuro de Guatemala no tiene que ser ese. Como ya hemos comentado, las mismas fuerzas populares que se movilizan contra el gobierno han apoyado el proceso de rescate.De la diáspora guatemalteca y de la clase obrera internacional han llegado decenas de miles de dólares en donaciones mediante la página GoFundMe (https://www.gofundme.com/helping-guatemalan-volcano-victims/donate). Esos fondos se han puesto a la disposición de las cooperativas locales para enfrentarse a la crisis. Cuba, gran ejemplo de la solidaridad internacional, ha enviado una brigada de médicos.No hay razón por la que Guatemala tiene que ser tan pobre como es, cuando sus campos han enriquecido al mundo con café, azúcar, algodón, y sobretodo, bananas. La culpa de tanto sufrimiento primero fue del sistema colonialista, que ahora ha sido reemplazado por el imperialismo neocolonial.La única fuerza capaz de resolver la actual crisis de manera que beneficie al pueblo, es el mismo pueblo. Seguramente es porque reconocen eso que Codeca exige: una Asamblea Nacional Constituyente Popular y Plurinacional.Que el proceso sea plurinacional es tan importante como que sea popular. En un país colonizado, donde las naciones herederas de los maya han sido siempre la mayoría, pero siempre las más pobres y oprimidas, no se puede avanzar sin rectificar tal injusticia.Y la única verdadera forma de rectificar tantos siglos de crueldad es con un movimiento social de carácter popular encabezado por los sectores más oprimidos del pueblo.FacebookTwitterWhatsAppEmailPrintMoreShare thisFacebookTwitterWhatsAppEmailPrintMoreShare thislast_img read more

Economists Give USDA Tips on Improving Reports

first_img SHARE Previous articleState Fair Announces “Year of the Coliseum” for 2014 FairNext articleSenators Call for RFS Revision Gary Truitt SHARE Facebook Twitter By Gary Truitt – Jan 23, 2014 Home Indiana Agriculture News Economists Give USDA Tips on Improving Reports Facebook Twitter Economists Give USDA Tips on Improving Reports Three professors at the University of Illinois – including Ag Economist Darrel Good – have released an evaluation and recommendations for improving USDA’s World Agricultural Supply and Demand Estimates, Crop Production and quarterly Grain Stocks reports. The research was requested and funded by USDA. According to USDA Chief Economist Joseph Glauber – some of those recommendations will be easier to implement than others. In fact – Glauber believes USDA can get to work on some of them very quickly. Others will take more time. Determining the feasibility of a feed use survey for corn is one that will take some time. The University of Illinois professors found that large, unresolved sampling errors in January Crop Production in 2009, 2010 and 2012 most likely caused distortions in the Grain Stocks report for corn. They suggested USDA look into conducting a feed survey to better help reconcile the feed and residual category on the corn balance sheet. The economists suggested – due to the diversity of the feeding industry – that USDA consider taking advantage of consolidation in the livestock industry and sample the largest feeders in each of the major species. Glauber says the economists have given the department a lot to consider moving forward. He notes the department will have to determine what can reasonably be done and what it will cost.Other suggestions focused on increasing transparency around how the World Agricultural Outlook Board arrives at its yield estimates for the May, June and July WASDE reports and how NASS arrives at its yield estimates. According to Glauber – the board already had methodology documents – but they aren’t highlighted by the agency. He says those documents will likely be published on the Internet and linked to in the footnotes of future WASDE reports.For more on the suggestions from the University of Illinois economists – visit farmdocdaily dot Illinois dot edu (https://farmdocdaily.illinois.edu). They were posted January 17th. Source: NAFB News servicelast_img read more

Cameroon journalist expelled for bogus reasons

first_img ChadAfrica October 15, 2009 – Updated on January 20, 2016 Cameroon journalist expelled for bogus reasons The 2020 pandemic has challenged press freedom in Africa Organisation Receive email alerts RSF_en ChadAfrica News Follow the news on Chad Many historic publications threatened with closure in Chad December 1, 2020 Find out morecenter_img to go further November 27, 2020 Find out more Reports Help by sharing this information October 7, 2020 Find out more News Chadian radio stations on strike in protest against violent raid News Innocent Ebodé, editor of the privately-owned weekly La Voix published in the capital N’Djamena was expelled from Chad yesterday after the authorities accused the Cameroon national of “staying illegally” in Chad.“The summary expulsion of this editor is both shocking and unwarranted”, Reporters Without Borders said. “This may well be the first move in a bid to gag this newspaper since it seems likely La Voix could be made to pay for his alleged ’irregularity’”.“And why should this happen now, when the weekly has been publishing since May this year? We urge the authorities to provide an immediate explanation”, the worldwide press freedom organisation said.Ebodé was yesterday taken by Chadian officials to the Cameroon side of the border city of Kousseri, after being summoned in the morning by state security officials in N’Djamena, and taken from there to counter intelligence, where after a two-hour interview in the presence of his two lawyers the journalist was told that he was “staying illegally”. He had in fact lost his passport and his residency permit but holds a consular ID card.The newspaper on 13 October carried a front page article headlined “Purchase of weapons in France: Chad spends 8.5 billions CFA francs”, based on official information released by the French defence ministry, revealing that Chad had become France’s second biggest customer for military hardware.Three weeks earlier, La Voix published an article referring to the likely departure of the Prime Minister, Youssouf Saleh Abbas, and speculating about his possible successor. The presidency issued a statement accusing the newspaper of aiming to “undermine the administration”. Other sources suggested that the weekly could have been targeted for a recent article about embezzlement within the Bank of Central African States (BEAC).“The pretext used by the authorities to expel me does not hold water. I have a consular card and Chad and Cameroon are members of The Economic and Monetary Community of Central Africa (CEMAC), I should therefore be allowed to move around and work freely”, Ebodé told Reporters Without Borders. “I think that above all our articles anger the authorities and they want to deprive the newspaper of my leadership”.last_img read more

In latest provocative move, authorities say heroin found on imprisoned journalist

first_img June 8, 2021 Find out more AzerbaijanEurope – Central Asia News Russian peacekeepers deny foreign reporters access to Nagorno-Karabakh News Follow the news on Azerbaijan AzerbaijanEurope – Central Asia Help by sharing this information Eynulla Fatullayev, a newspaper editor who is serving an eight-year sentence in a high-security, prison, could face an additional three-year jail term after 0.22 grams of heroin were allegedly found in his clothes on 29 December, in what appears to be the latest provocative move in the government’s persecution of opposition and independent journalists.“Azerbaijan’s leaders seem ready to stop at nothing in order to keep Fatullayev behind bars,” Reporters Without Borders said. “With his complaint against Azerbaijan due to be examined soon by the European Court of Human Rights, this is an extremely opportune development for those opposed to his release.”The press freedom organisation added: “President Aliev should make it clear to the country’s authorities that they should stop resorting to procedures that fool no one about their purpose and just harm Azerbaijan’s image.”The authorities say they are investigating the discovery of 0.22 grams of heroin during a search of Fatullayev’s cell at prison camp No. 12 (12 km outside Baku) on 29 December. He could get an additional three-year jail sentence if found guilty of possessing drugs. He has been placed in solitary confinement since the discovery.The founder and editor of the weekly Realny Azerbaijan and the daily Gundelik Azerbaijan, Fatullayev was sentenced to 30 months in prison on 20 April 2007 under article 14.2 of the criminal code for allegedly defaming and insulting Azerbaijanis in comments he was alleged to have posted online. The posts accused the Azerbaijani armed forces of sharing responsibility with their Armenian counterparts for the deaths of hundreds of civilians during an attack by Armenian troops in 1992 on the village of Khojali in the disputed Nagorno-Karabakh region. His sentence was increased to eight years in prison in July 2007 after he was found guilty on additional charges of terrorism and inciting racial and religious hatred.Fatullayev’s persecution by the Azerbaijani authorities has been referred by his lawyer to the European Court of Human Rights, which is due to consider the case shortly.A respected journalist, Fatullayev used to work for the magazine Monitor, whose editor, Elmar Husseynov, was murdered in March 2005. The Russian-language daily that Fatullayev founded, Realny Azerbaijan, was outspoken in its criticism of the government and had a print run of 30,000. The authorities closed both of his newspapers following his arrest and many of their employees were harassed by the police.This would not be the first time the authorities have brought a spurious drug charge against an outspoken journalist. Sakit Zahidov, a writer and reporter for the leading opposition daily, Azadlig, was sentenced to three years in prison in October 2006 on a clearly trumped-up charge of drug possession. One other journalist is currently detained in Azerbaijan in addition to Fatullayev. It is Zahidov’s brother, Azadlig editor Ganimat Zahidov. RSF_en Receive email alertscenter_img News “We’ll hold Ilham Aliyev personally responsible if anything happens to this blogger in France” RSF says to go further RSF calls for a fully transparent investigation after mine kills two journalists in Azerbaijan News June 4, 2021 Find out more December 31, 2009 – Updated on January 20, 2016 In latest provocative move, authorities say heroin found on imprisoned journalist Organisation April 9, 2021 Find out morelast_img read more

Global Castrate-resistant Prostate Cancer Market (2020 to 2027) – Size, Share & Trends Analysis…

first_img Facebook TAGS  By Digital AIM Web Support – February 4, 2021 Pinterest Global Castrate-resistant Prostate Cancer Market (2020 to 2027) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com Previous articleMiraMed Introduces Dee Repici, General CounselNext articleElvis Presley’s Graceland Offers Additional Virtual Live VIP Tours After Initial Sell-Out Digital AIM Web Support Twitter WhatsAppcenter_img Facebook DUBLIN–(BUSINESS WIRE)–Feb 4, 2021– The “Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), by Region, and Segment Forecasts, 2020-2027” report has been added to ResearchAndMarkets.com’s offering. The global castrate-resistant prostate cancer market size is expected to reach USD 16.2 billion by 2027. The market is expected to expand at a CAGR of 8.4% from 2020 to 2027. This growth is driven by the rising global burden of castrate-resistant prostate cancer and unhealthy lifestyle. In addition, the anticipated launch of new products and rising awareness of prostate cancer are likely to enhance the growth rate of the market over the forecast period. Moreover, the growing adoption of novel drugs and strong pipeline are factors likely to accelerate market growth during the forecast period. The hormonal therapy segment dominated the market and held the largest revenue share of 83.1% in 2019. The segment is driven by increasing market penetration of Xtandi (enzalutamide) and the launch of Erleada (apalutamide) in the U.S., Europe, and Japan. Furthermore, the development and approval of an additional indication of Xtandi are driving the segment growth. In addition, immunotherapy is estimated to be the fastest-growing segment due to the presence of strong product pipeline drugs, which are projected to be launched during the forecast period. North America’s dominant share is attributable to high disease burden, technological advancements, proactive government measures, increased consumer awareness about the disease, and improvements in healthcare infrastructure. The presence of key players in this region is a key factor in boosting the growth of the market in the region. In addition, developing countries such as India and China are witnessing a high incidence of the disease that has resulted in an increase in the demand for improved therapeutics, an increase in healthcare expenditure, and a rise in government funding for oncology and other research activities. Thus, these factors are expected to drive the market in the Asia Pacific during the forecast period. Companies MentionedSanofiJohnson & Johnson Services Inc.Pfizer Inc.Astellas Pharma, Inc.Bayer AG Castrate-resistant Prostate Cancer Market Report HighlightsProstate cancer is the highest prevalent cancer in men. 1 in 9 men are diagnosed with prostate cancer.Within 3 years of diagnosis, 10-50% of overall prostate cancer cases develop into metastatic castrate-resistant prostate cancer.The recommendation of products from healthcare authorities is expected to increase the sales of the drug, thereby fueling market growth. For instance, Provenge is recommended by the Society for Immunotherapy of Cancer, the National Comprehensive Cancer Network, and the American Urological Association.Australia and New Zealand have the highest prevalence rate of the disease, followed by North America and Europe.In Asia Pacific, the market is likely to witness the fastest CAGR of 11.5% from 2020 to 2027. Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Castrate-Resistant Prostate Cancer Market Variables, Trends & Scope 3.1. Castrate-Resistant Prostate Cancer Market Lineage outlook 3.1.1. Parent market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. User Perspective Analysis 3.4. Regulatory Framework 3.5. Market Dynamics 3.5.1. Market driver analysis 3.5.1.1. Rising prevalence of castrate-resistant prostate cancer 3.5.1.2. Increasing technological advancements 3.5.1.3. Rising adoption of treatment 3.5.2. Market restraint analysis 3.5.2.1. Lack of standard therapy 3.6. Castrate-Resistant Prostate Cancer Market Analysis Tools 3.6.1. Industry Analysis – Porter’s 3.6.1.1. Supplier Power 3.6.1.2. Buyer Power 3.6.1.3. Substitution Threat 3.6.1.4. Threat from New Entrant 3.6.1.5. Competitive Rivalry 3.6.2. PESTEL Analysis 3.6.2.1. Political Landscape 3.6.2.2. Environmental Landscape 3.6.2.3. Social Landscape 3.6.2.4. Technology Landscape 3.6.2.5. Legal Landscape Chapter 4. Castrate-Resistant Prostate Cancer Market: Therapy Estimates & Trend Analysis 4.1. Definitions & Scope 4.2. Therapy Market Share Analysis, 2019 & 2027 4.3. Therapy Dashboard 4.4. Castrate-Resistant Prostate Cancer Market, By Therapy, 2016 to 2027 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following, Chapter 5. Castrate-resistant Prostate Cancer Market: Segment Analysis, By Region, 2016 – 2027 (USD Million) 5.1 Castrate-resistant Prostate Cancer Market, Market Share by Region, 2019 & 2027 5.1.1 North America 5.1.2 Europe 5.1.3 Asia Pacific 5.1.4 Latin America 5.1.5 Middle East and Africa Chapter 6. Company Profiles 6.1. Recent developments & impact analysis, by key market participants 6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players) 6.3. Public Companies 6.4. Private Companies 6.5. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/k48r4p View source version on businesswire.com:https://www.businesswire.com/news/home/20210204005753/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press[email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: RADIOLOGY PHARMACEUTICAL HEALTH ONCOLOGY SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/04/2021 10:04 AM/DISC: 02/04/2021 10:04 AM http://www.businesswire.com/news/home/20210204005753/en WhatsApp Twitter Pinterest Local NewsBusinesslast_img read more

Quotient Announces Agreement to Power In-Lane Digital Promotions for Major Drug Retailer

first_img Previous articleAustralian Open: Serena Williams vs. Naomi Osaka in semisNext articleVipergen Publishes First Technology for Screening DNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells Digital AIM Web Support Facebook Quotient Announces Agreement to Power In-Lane Digital Promotions for Major Drug Retailer WhatsApp Facebook Pinterest TAGS  Pinterestcenter_img MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Feb 17, 2021– Quotient (NYSE: QUOT), the leading digital media and promotions technology company, announced today it will launch In-Lane Digital Promotions at a major drug retailer in the second half of 2021, which will deliver proprietary targeted promotions through offline receipts printed at checkout. This marks an expansion of the retailer’s use of the Quotient Retailer Promotions Platform, which drives incremental sales through strategic, integrated promotions for leading retailers and over 2000 U.S. brands. Quotient’s In-Lane solution plays a critical role in retailer omnichannel marketing strategies, enabling them to reach millions of shoppers in-store and at the checkout with promotions and messages from both the retailer and their advertiser partners. Through this solution, offers and other content are conveniently delivered on customers’ shopping receipts, targeted based on shopper purchase data to provide personalization and maximum value for consumers, and an optimum conversion-rate for brands. With over 90% of consumers still making a physical shopping trip at least once a week during the pandemic 1, the In-Lane solution provides brands with an opportunity to drive incremental sales through new physical exposure of their brand and promotions with more shoppers. It significantly increases the reach of Quotient’s targeted offers and creates an additional integrated touchpoint for the delivery of promotions, with both shoppers that prefer a mixed mode of digital and physical shopping, as well as those that are not engaged yet through digital. “The in-store environment is a key part of the path-to-purchase, and as such it is an important part of Quotient’s omnichannel approach to strategic media and promotions,” said Henri Lellouche, VP of In-Store Solutions. “We are pleased to announce the expansion of our partnership with a major chain drug retailer – the first drug addition to Quotient’s growing In-Lane retailer network, which we expect will expand further as Quotient continues to disrupt the status quo as a leader in transformation and consumer-driven innovation,” added Mr. Lellouche. In-Lane Digital Promotions will be available to advertisers at this major drug retailer in the second half of 2021. About Quotient Quotient (NYSE: QUOT) is the leading digital media and promotions technology company that creates cohesive omnichannel brand-building and sales-driving opportunities to deliver valuable outcomes for advertisers, retailers and consumers. The Quotient platform is powered by exclusive consumer spending data, location intelligence and purchase intent data to reach millions of shoppers daily and deliver measurable, incremental sales. Quotient partners with leading advertisers and retailers, including Clorox, Procter & Gamble, General Mills, Unilever, Albertsons Companies, CVS, Dollar General and Peapod Digital Labs, a company of Ahold Delhaize USA. Quotient is headquartered in Mountain View, California, and has offices across the US as well as in Bangalore, Paris, London and Tel Aviv. For more information visit www.quotient.com Quotient is the registered trademark of Quotient Technology Inc. in the United States and other countries. 1 Source: Ubimo Consumer Survey Report 2020. Ubimo is a subsidiary of Quotient. View source version on businesswire.com:https://www.businesswire.com/news/home/20210217005277/en/ CONTACT: Brands2Life on behalf of Quotient Rachel Gossel 415-610-7500 E:[email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: SOFTWARE NETWORKS PHARMACEUTICAL INTERNET MEDICAL SUPPLIES HEALTH DATA MANAGEMENT TECHNOLOGY SOURCE: Quotient Copyright Business Wire 2021. PUB: 02/17/2021 07:59 AM/DISC: 02/17/2021 07:59 AM http://www.businesswire.com/news/home/20210217005277/en By Digital AIM Web Support – February 17, 2021 Local NewsBusiness Twitter WhatsApp Twitterlast_img read more